Pancreatic Carcinoma — Trials

Pancreatic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,381 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 488
Recruiting: 282
Ph III recruiting: 29
Growth YoY: +31.5%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

clinicaltrialsPublishedShowing 151–156 of 156 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00075647	CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer	completed	Phase 2	40	National Cancer Institute (NCI)NIH	1	Jan 17, 2013	clinicaltrials
NCT01543412	Second Line Chemotherapy for Advanced Pancreatic Cancer(SLAP)	completed	Phase 2	50	Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER	1	Mar 5, 2012